GM2-gangliosidosis B1 variant: A wide geographic and ethnic distribution of the specific β-hexosaminidase α chain mutation originally identified in a puerto rican patient
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 156 (2) , 1015-1019
- https://doi.org/10.1016/s0006-291x(88)80945-8
Abstract
No abstract availableFunding Information
- U.S. Public Health Service
This publication has 9 references indexed in Scilit:
- Splice junction mutation in some Ashkenazi Jews with Tay-Sachs disease: evidence against a single defect within this ethnic group.Proceedings of the National Academy of Sciences, 1988
- Identification of an altered splice site in Ashkenazi Tay-Sachs diseaseNature, 1988
- A splicing defect due to an exon-intron junctional mutation results in abnormal β-hexosaminidase α chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs diseaseBiochemical and Biophysical Research Communications, 1988
- Mutation in GM2‐Gangliosidosis B1 VariantJournal of Neurochemistry, 1988
- Organization of the gene encoding the human beta-hexosaminidase alpha-chain.Journal of Biological Chemistry, 1987
- Prenatal Diagnosis of GM2 Gangliosidosis with High Residual Hexosaminidase A Activity (Variant B1; Pseudo AB Variant)Pediatric Research, 1985
- Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.The EMBO Journal, 1983
- A new variant of Type-AB GM2-gangliosidosisBiochemical and Biophysical Research Communications, 1981
- The AB-variant of GM2-gangliosidosisActa Neuropathologica, 1980